A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cerecin
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy males and non-pregnant, non-lactating healthy females aged 18 to 55 years inclusive at time of signing informed consent with a body weight ≥55 kg.
Body mass index (BMI) 18.0 to 32.0 kg/m2 as measured at screening or, if outside the range, considered not clinically significant by the investigator.
You may not be if
Serious adverse reaction or serious hypersensitivity to any drug or formulation excipients
Subjects with a history of fainting, dizziness, bradycardia or hypotension as considered clinically significant by the investigator
Subject has a medical condition that may adversely affect taste or smell activity
Clareo Health | A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects
